Oops, Y-mAbs Gets a ‘Not Quite Ready’ Letter for Omburtamab Biologics License Application!

Hey there cancer warriors! So you might have heard the news… Y-mAbs has got some news for us Now, I know what you’re thinking. Another day, another biopharmaceutical company making headlines. But this time, it’s different. Y-mAbs Therapeutics, Inc. just announced that the FDA has issued a complete response letter for their Omburtamab Biologics License…

Read More

Francisco Oliva Appointed as Business Development Manager for South America at Nikkiso Clean Energy and Industrial Gases Group

Francisco Oliva Named Business Development Manager, South America for Nikkiso Clean Energy and Industrial Gases Group Introduction TEMECULA, Calif., Dec. 01, 2022 (GLOBE NEWSWIRE) — Nikkiso Cryogenic Industries’ Clean Energy & Industrial Gases Group (“Group”), a part of the Nikkiso Co., Ltd (Japan) group of companies, is pleased to announce that Francisco Oliva has been…

Read More

Regulators Take Action Against TINA.org’s Complaint Towards Rihanna’s Savage x Fenty

Lingerie Company Settles Lawsuit for $1.2 Million Regulators Act on TINA.org’s Complaint Against Rihanna’s Savage X Fenty Charmingly eccentric, full of personality, and designed for maximum reader engagement, the lingerie company Savage X Fenty has recently settled a lawsuit for $1.2 million. California regulators took action based on a complaint filed by ad watchdog truthinadvertising.org…

Read More

Breaking News: Middlefield Banc Corp Successfully Merges with Liberty Bancshares Inc

Ronald L. Zimmerly, Jr. appointed as President of Middlefield Banc Corp. Ronald L. Zimmerly, Jr., Mark R. Watkins, and Spencer T. Cohn appointed to Middlefield’s Board of Directors MIDDLEFIELD, Ohio, Dec. 01, 2022 (GLOBE NEWSWIRE) — Middlefield Banc Corp. (“Middlefield”, or the “Company”) (NASDAQ: MBCN), the bank holding company for The Middlefield Banking Company It’s…

Read More

Breaking News: GSR II Meteora Acquisition Corp. Files Amended Proxy Statement, Bitcoin Depot Reports Impressive Q3 Results

Bitcoin Depot Delivers Record Year-to-Date Revenue Growth of 25% NEW YORK, Dec. 01, 2022 (GLOBE NEWSWIRE) — GSR II Meteora Acquisition Corp. (NASDAQ: GSRM) (“GSRM”), a special purpose acquisition company, and Lux Vending LLC dba Bitcoin Depot Inc. (“Bitcoin Depot” or the “Company”), a U.S.-based Bitcoin ATM operator and leading fintech company, announced today that…

Read More

Innovative, Articulate, and Easy to Follow: A Professional Flair for Rapid Micro Biosystems’ Strategic Alternatives

Rapid Micro Biosystems Concludes Review of Strategic Alternatives Introduction In a recent announcement, Rapid Micro Biosystems, Inc. revealed that its Board of Directors has completed its thorough review of strategic alternatives. The company, known for its innovative life sciences technology solutions, is listed on the Nasdaq under the ticker symbol RPID. Rapid Micro Biosystems specializes…

Read More

Unlocking the Potential of CT1812: A Promising Treatment for Dry AMD – Cognition Therapeutics Unveils Scientific Evidence and Clinical Trial Plans

Cognition Therapeutics Presents Scientific Rationale, Clinical Biomarker and Preclinical Data PURCHASE, N.Y., Dec. 01, 2022 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (Nasdaq: CGTX), (the “Company” or “Cognition”) today announced that the scientific rationale, supporting proof-of-concept data and design of the planned Phase 2 trial of CT1812 in geographic atrophy (GA) secondary to dry age-related macular…

Read More

Maximizing Profitability: Advantest Introduces E5620 DR-SEM for Precise Review and Classification of Ultra-Small Photomask Defects

Advantest Unveils E5620 DR-SEM for Review and Classification of Ultra-Small Photomasks Overview Advantest Corporation has introduced its latest cutting-edge technology, the E5620 Defect Review Scanning Electron Microscope (DR-SEM). This innovative mask SEM product is designed to review and classify ultra-small defects on photomasks and mask blanks with high precision and efficiency. Features The E5620 DR-SEM…

Read More